A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1
Clinical trial NCT02572388 · COMPLETED
Trial details
- NCT number
- NCT02572388
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-15
- Primary completion
- 2017-08-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.